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Abstract
Background: b-lapachone (b-lap), has been known to cause NQO1-dependnet death in cancer cells and sensitize cancer
cells to ionizing radiation (IR). We investigated the mechanisms underlying the radiosensitization caused by b-lap.
Methodology/Principal Findings: b-lap enhanced the effect of IR to cause clonogenic cells in NQO1
+-MDA-MB-231 cells but
not in NQO1
2-MDA-MB-231 cells. b-lap caused apoptosis only in NQO1
+ cells and not in NQO1
2 cells and it markedly
increased IR-induced apoptosis only in NQO1
+ cells. Combined treatment of NQO1
+ cells induced ROS generation, triggered
ER stress and stimulated activation of ERK and JNK. Inhibition of ROS generation by NAC effectively attenuated the
activation of ERK and JNK, induction of ER stress, and subsequent apoptosis. Importantly, inhibition of ERK abolished ROS
generation and ER stress, whereas inhibition of JNK did not, indicating that positive feedback regulation between ERK
activation and ROS generation triggers ER stress in response to combined treatment. Furthermore, prevention of ER stress
completely blocked combination treatment-induced JNK activation and subsequent apoptotic cell death. In addition,
combined treatment efficiently induced the mitochondrial translocation of cleaved Bax, disrupted mitochondrial membrane
potential, and the nuclear translocation of AIF, all of which were efficiently blocked by a JNK inhibitor. Caspases 3, 8 and 9
were activated by combined treatment but inhibition of these caspases did not abolish apoptosis indicating caspase
activation played a minor role in the induction of apoptosis.
Conclusions/Significance: b-lap causes NQO1-dependent radiosensitization of cancer cells. When NQO1
+ cells are treated
with combination of IR and b-lap, positive feedback regulation between ERK and ROS leads to ER stress causing JNK
activation and mitochondrial translocation of cleaved Bax. The resultant decrease in mitochondrial membrane leads to
translocation of AIF and apoptosis.
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Introduction
b-lapachone (b-lap) is a bioreductive agent that has been
shown to possess strong anti-cancer activity both in vitro and in
vivo [1–3]. The anti-cancer activity of b-lap has been shown to be
due to the two-electron reduction of b-lap mediated by
NAD(P)H:quinone oxidoreductase (NQO1, DT-diaphorase)
using NADH or NAD(P)H as electron sources [1–3]. Because
NQO1 is expressed more abundantly in a variety of human solid
cancers than in normal tissues [1–3], b-lap can selectively kill
human cancer cells. b-lap has also been shown to sensitize
cancer cells to ionizing radiation (IR) [4]. However, the precise
underlying this radiosensitizing mechanism has not yet been
elucidated.
Futile cycling between the oxidized and reduced forms of b-lap
has been shown to cause progressive depletion of NADH and
NAD(P)H, which, in turn induces massive release of Ca
2+ from
the endoplasmic reticulum (ER) into the cytosol, leading to
activation of the Ca
2+-dependent proteinase, calpain and
subsequent apoptotic cell death [1,2,5]. Furthermore, redox
cycling caused by one-electron reduced b-lap (i.e., the semiqui-
none form of b-lap), the intermediate between two-electron b-lap
and the oxidized form of b-lap can trigger the activation of cell
death pathways [1]. Recent studies suggest that generation of
reactive oxygen species (ROS) by diverse cell death stimuli does
not only initiate cascades of cell death signals but also directly
lead to DNA damage [6–10]. However, the signaling pathways
activated by ROS in cells treated with b-lap have not yet been
clearly delineated.
Although b-lap was demonstrated to activate mitogen-activated
protein kinases (MAPKs) in cancer cells, and thereby induce
apoptotic death [11], the signaling pathways involved in the
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e25976activation of MAPKs caused by b-lap, and the precise role of
MAPK activation in b-lap-induced apoptosis have not been
clarified.
The mitochondrial cell death pathway is regulated by the ratio
of pro- to anti-apoptotic proteins, including members of the Bcl-2
family. Among these family members, Bax or Bak plays a key role
in the loss of mitochondrial transmembrane potential [12]. Upon
delivery of an apoptotic stimulus, cytosolic Bax translocates to the
outer mitochondrial membrane, where it oligomerizes to form
homodimers, creating pores that expedite the release of cyto-
chrome c, apoptosis-inducing factor (AIF), and endonuclease G
(Endo G) from the intermembrane space of the mitochondrion
into the cytosol [7].
In this study, we investigated the mechanism by which b-lap
modulates the response of breast cancer cells to radiation. We
demonstrate here that combined treatment of IR and b-lap
synergistically increases clonogenic and apoptotic cell death in
an NQO1-dependent manner. We also show that the generation
of ROS, induction of ER stress, and activation of extracellular-
regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) by
combined treatment are crucial for mitochondrial apoptotic cell
death. Specifically, we concluded that formation of a positive
feedback loop between ERK activation and ROS generation is
needed for combined treatment-induced ER stress, which leads
to JNK activation and subsequent mitochondrial apoptotic cell
death. Our data provide a potential mechanism to account for
the radiosensitizing effect of b-lap, and insight gained in the
present study will lead to advances in the clinical application of
combined treatment with IR and b-lap in therapies based on
NQO1-directed tumor targeting.
Results
Combined treatment with IR and b-lap increases
clonogenic and apoptotic cell death in an NQO1-
dependent manner
To determine the effect of b-lap on clonogenic cell survival, we
treated parental NQO1
2-MDA-MB-231 cells deficient in NQO1,
or NQO1
+-MDA-MB-231 cells possessing abundant expression of
NQO1, with different doses of b-lap. As shown in Figure 1A, a
dose dependent increase in clonogenic cell death following b-lap
treatment was obvious in NQO1
+-MDA-MB-231 cells, but not in
parental NQO1
2-MDA-MB-231 cells, indicating NQO1 plays a
crucial role for the b-lap-induced cell death.
We analyzed the effect of b-lap on the IR-induced clonogenic
death of NQO1
2-MDA-MB-231 and NQO1
+-MDA-MB-231
cells. Cells were exposed to different doses of IR in the presence or
absence of 2 mM b-lap and the clonogenic survival was
determined as shown in Fig. 1B. The radiation survival curves
for combined treatment were normalized for the death by b-lap
alone. The radiation survival curve for combined treatment with
IR and b-lap was identical in NQO1
+-MDA-MB-231 cells. On the
other hand, the radiation survival curve for combined treatment of
NQO1
+-MDA-MB-231 cells was significantly steeper particularly
at the lower radiation doses than that for IR treatment alone
resulting in significant decrease in the shoulder of the survival
curve. The reduction of shoulder indicated that b-lap inhibited the
repair of sublethal radiation damage in NQO1
+ cells but not in
NQO1
2 cells.
We investigated the combined effect of IR and b-lap on
apoptotic cell death in NQO1
2-MDA-MB-231 and NQO1
+-
Figure 1. b-lap induces radiosensitization in an NQO1-dependent manner. (A) NQO1
2 or NQO1
+-MDA-MB-231 cells were treated with
various concentrations of b-lap. Cells were allowed to grow for 10 to 14 days and were stained with 0.5% crystal violet and scored for colony
formation. Results from three independent experiments are expressed as means 6 SEM. *Significant difference between NQO1
2- and NQO1
+-MDA-
MB-231 cells after b-lap treatment at p,0.05. (B) Cells were treated with 2 mM b-lap and then exposed to increasing doses of IR 30 min after
treatment with b-lap. After 14 days, cells were scored for colony formation. Results from three independent experiments are expressed as means 6
SEMs. (C) Cells were treated with IR alone, b-lap alone or the combination of IR and b-lap for the indicated times. The percentage of cells with sub-G1
DNA content was determined by flow cytometry. Results from three independent experiments are expressed as means 6 SEMs.
doi:10.1371/journal.pone.0025976.g001
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2 mM b-lap alone, or combination of IR and b-lap for various
lengths of time, and apoptotic cell death was assessed. While
apoptosis of NQO1
+-MDA-MB-231 cells induced by IR alone was
about 13 and 14% at 24 and 48 h, respectively, b-lap alone-
induced apoptosis in about 18 and 40% of cells at 24 and 48 h,
respectively (Fig. 1C). Combined treatment with IR and b-lap
remarkably increased apoptotic cell death in NQO1
+-MDA-MB-
231 cells; about 58 and 87% of cells were apoptotic at 24 and
48 h, respectively. On the contrary, in NQO1
2-MDA-MB-231
cells, no significant apoptosis occurred after treating with IR or b-
lap alone or even with combination of IR and b-lap, most likely
due to NQO1 deficiency and a mutant form of p53 expressed in
NQO1
2-MDA-MB-231 cells [13].
Combined treatment with IR and b-lap markedly induces
ROS generation in NQO1
+-MDA-MB-231 cells
We investigated the involvement of ROS in combined
treatment-induced apoptotic cell death in NQO1
2-MDA-MB-
231 and NQO1
+-MDA-MB-231 cells. We first measured ROS
with DCF staining. Compared to individual treatment with IR
or b-lap, combined treatment caused far more increase in ROS
levels for 3 h in NQO1
+-MDA-MB-231 cells but not in
NQO1
2-MDA-MB-231 (Fig. 2A). We further confirmed the
ROS generation by combined treatment with IR and b-lap using
another ROS detection dye, dihydroethidium (DHE). As shown
in Figure 2B, we observed marked increase in ROS generation
in NQO1
+-MDA-MB-231 cells but not in NQO1
2-MDA-MB-
231 cells after combined treatment with IR and b-lap. To
determine whether the increase in intracellular ROS levels was
directly related to apoptotic cell death, we pretreated NQO1
+-
MDA-MB-231 cells with the antioxidant NAC before exposing
cells to IR and b-lap. As shown in Figure 2C, pretreatment with
NAC significantly reduced the apoptotic cell death caused by
combined treatment with IR and b-lap. Furthermore, pretreat-
ment with NAC effectively attenuated the clonogenic cell death
caused by combined treatment with IR and b-lap (Fig. 2D).
These observations suggest that induction of ROS critically
contributes to the apoptotic and clonogenic cell death caused by
combined treatment with IR and b-lap in NQO1
+-MDA-MB-
231 cells.
b-lap in combination with IR rapidly activates ERK and
JNK, leading to apoptotic cell death
To reveal the potential involvement of MAPKs in the apoptotic
cell death caused by combined treatment with IR and b-lap, we
studied the levels of the activated forms of MAPKs in NQO1
2-
MDA-MB-231 and NQO1
+-MDA-MB-231 cells by Western blot
analysis using anti-phospho antibodies. As shown in Figure 3A, in
NQO1
2-MDA-MB-231 cells, IR alone slightly increased phos-
phorylation of ERK and JNK while b-lap alone caused little
change in the levels of phosphorylated ERK and JNK. The effect
of combined treatment was similar to that of IR alone. The
phosphorylation of p38 MAPK in NQO1
2-MDA-MB-231 cells
was negative after either single or combined treatments with IR
and b-lap. However, in NQO
+-MDA-MB-231 cells, combined
treatment led to a rapid up-regulation of phosphorylated ERK
and JNK as compared with the treatment with IR alone or b-lap
alone (Fig. 3A). ERK activation was apparent at 0.5 h, and
remained elevated for 3 h after combined treatment. In addition,
Figure 2. b-lap in combination with IR enhances ROS generation and leads to apoptotic cell death. (A) and (B) Cells were treated with IR
alone, b-lap alone or combination of IR and b-lap for the indicated times. After 3 h, the cells were incubated with 10 mM H2DCF-DA and 4 mM DHE,
respectively, for 30 min and then analyzed by flow cytometry. Results from three independent experiments are expressed as means 6 SEMs. (C)
NQO1
+-MDA-MB-231 cells were treated with IR alone, b-lap alone or combination of IR and b-lap for 24 h in the presence or absence of NAC (10 mM).
After 24 h, the percentage of cells with sub-G1 DNA content was determined by flow cytometry. Results from three independent experiments are
expressed as means 6 SEMs. (D) NQO1
+-MDA-MB-231 cells were treated with combination of IR (2 Gy) and b-lap (2 mM) in the presence or absence of
NAC (10 mM). Cells were allowed to grow for 10 to 14 days and were stained with 0.5% crystal violet and scored for colony formation. Results from
three independent experiments are expressed as means 6 SEM. *Significant difference between cells in the presence or absence of NAC after
combined treatment with IR and b-lap, at p,0.05.
doi:10.1371/journal.pone.0025976.g002
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after combined treatment in NQO1
+-MDA-MB-231 cells. The
total cellular levels of ERK and JNK remained constant. IR
treatment increased phosphorylation of p38 MAPK, while b-lap
treatment caused no change in phosphorylation of p38 MAPK.
The phosphorylation level of p38 MAPK after combined
treatment was lower than that after treatment with IR alone,
indicating b-lap suppressed IR-induced activation of p38 MAPK
in NQO1
+-MDA-MB-231 cells (Fig. 3A). To examine the
relationship between the activation of MAPKs and apoptotic
cell death, we pretreated NQO1
+-MDA-MB-231 cells with
SP600125, PD98059, or SB203580, inhibitors of JNK, MEK/
ERK, and p38 MAPK, respectively, prior to treatment with IR
and b-lap. As shown in Figure 3B, PD98059 and SP600125
effectively reduced the apoptotic cell death caused by combined
treatment from 56% to 24% and 13%, respectively, whereas
SB203580 was ineffective. To further investigate the involvement
of ERK and JNK2 in the apoptotic cell death caused by
combined treatment with IR and b-lap, we pretreated NQO1
+-
MDA-MB-231 cells with siRNAs targeting ERK and JNK2.
Consistent with the results obtained with pharmacological
inhibitors, specific inhibition of ERK and JNK2 with siRNAs
almost completely abolished the apoptotic cell death caused by
combined treatment (Fig. 3C). These results demonstrate that
ERK and JNK act as important mediators of apoptotic cell death
induced by combined treatment with IR and b-lap in NQO1
+-
MDA-MB-231 cells.
Positive feedback regulation between ROS and ERK
induced by combined treatment with IR and b-lap is
essential for the activation of JNK
To determine whether ROS generation is involved in the
activation of ERK and JNK by combined treatment with IR and
b-lap, we pretreated NQO1
+-MDA-MB-231 cells with the
antioxidant NAC prior to treatment with IR and b-lap. As shown
in Figure 4A, the activation of ERK and JNK by combined
treatment was completely blocked by pretreatment with NAC. We
next examined the contribution of ERK and JNK to ROS
generation caused by combined treatment. We treated NQO1
+-
MDA-MB-231 cells with siRNAs targeting ERK and JNK2 prior
to treatment with IR and b-lap. As shown in Figure 4B, siRNA-
mediated ERK knockdown effectively blocked ROS generation, as
determined with DCF, induced by b-lap alone and to an even
greater extent by combined treatment, whereas siRNA targeting
JNK2 did not attenuate ROS generation.
To further elucidate the possibility of cross-talk between ERK
and JNK, we pretreated NQO1
+-MDA-MB-231 cells with
PD98059 or SP600125. As shown in Figure 4C, activation of
ERK and JNK by combined treatment was completely abrogated
by pretreatment with PD98059 and SP600125, respectively.
Figure 3. b-lap in combination with IR rapidly activates ERK and JNK. (A) NQO1
2 or NQO1
+-MDA-MB-231 cells were treated with IR alone, b-
lap alone or combination of IR and b-lap for the indicated times. The data represent a typical experiment conducted three times with similar results.
(B) and (C) NQO1
+-MDA-MB-231 cells were treated with IR alone, b-lap alone or combination of IR and b-lap for 24 h in the presence or absence of
PD98059 (30 mM), SP600125 (30 mM), SB203580 (30 mM), or siRNA targeting ERK1/2 or JNK2. The percentage of cells with sub-G1 DNA content was
determined by flow cytometry. Results from three independent experiments are expressed as means 6 SEMs.
doi:10.1371/journal.pone.0025976.g003
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induced activation of JNK, whereas SP600125 did not attenuate
the activation of ERK, indicating that ERK is an upstream
activator of JNK (Fig. 4C). These results indicated that b-lap in
combination with IR leads to positive feedback regulation between
ROS and ERK activation that may contribute to JNK activation.
ROS generation induced by combined treatment with IR
and b-lap is required for the induction of ER stress
We next investigated whether combined treatment with IR and
b-lap induces ER stress in NQO1
+-MDA-MB-231 cells using
phosphorylation of eIF2a and CHOP expression. As shown in
Figure 5A, IR alone did not alter phosphorylated eIF2a (p-eIF2a)
levels and CHOP expression, and b-lap alone slightly increased p-
eIF2a and CHOP expression. However, combined treatment
markedly induced p-eIF2a and increased CHOP expression level
(Fig. 5A). To further examine the involvement of ER stress in
apoptotic cell death induced by combined treatment with IR and
b-lap, we pretreated NQO1
+-MDA-MB-231 cells with Salubrinal
(Sal), an ER stress inhibitor. As shown in Figure 5B, Sal effectively
suppressed combination treatment-induced apoptotic cell death.
These results indicate that ER stress is a major contributor to
combined treatment-induced apoptotic cell death in NQO1
+-
MDA-MB-231 cells.
We next investigated the relationship between ROS generation
and ER stress in NQO1
+-MDA-MB-231 cells treated with
combination of IR and b-lap. As shown in Figure 5C, pretreat-
ment with Sal did not attenuate the ROS generation caused by
combined treatment, whereas pretreatment with NAC effectively
prevented the phosphorylation of eIF2a (Fig. 5D), indicating that
ROS generation induced by combined treatment is required for
the induction of ER stress.
ER stress induced by combined treatment with IR and b-
lap is required for the activation of JNK
To analyze the relationship between ER stress and MAPKs
(ERK and JNK), we first examined the effect of Sal on the
activation of ERK and JNK. As shown in Figure 5E, pretreatment
with Sal efficiently suppressed the activation of JNK induced by
combined treatment, but did not attenuate the activation of ERK.
To further establish the critical role of MAPKs in the induction of
ER stress, we pretreated NQO1
+-MDA-MB-231 cells with
PD98059 or SP600125. As shown in Figure 5F, combined
treatment-induced phosphorylation of eIF2a was completely
blocked by PD98059, but not by SP600125. These results indicate
that ERK is an upstream activator of ER stress responsible for
JNK activation in response to combined treatment with IR and b-
lap.
Combined treatment with IR and b-lap induces apoptotic
cell death through the nuclear translocation of AIF
Because activation of the caspase pathway is an important
mechanism for inducing apoptotic cell death [14], we investigated
the involvement of caspases in the apoptotic response to combined
treatment of NQO1
+-MDA-MB-231 cells with IR and b-lap. As
shown in Figure 6A, combined treatment led to activations of
Figure 4. b-lap in combination with IR induces positive feedback regulation between ERK and ROS. (A) NQO1
+-MDA-MB-231 cells were
treated with IR alone, b-lap alone or combination of IR and b-lap for 30 min in the presence or absence of NAC. The data represent a typical
experiment conducted three times with similar results. (B) NQO1
+-MDA-MB-231 cells were treated with IR alone, b-lap alone or combination of IR and
b-lap for 3 h in the presence or absence of siRNA targeting ERK1/2 or JNK2. After 3 h, the cells were incubated with 10 mM H2DCF-DA for 30 min and
then analyzed by flow cytometry. Results from three independent experiments are expressed as means 6 SEMs. (C) NQO1
+-MDA-MB-231 cells were
treated with IR alone, b-lap alone or combination of IR and b-lap for 30 min in the presence or absence of PD98059 or SP600125. The data represent a
typical experiment conducted three times with similar results.
doi:10.1371/journal.pone.0025976.g004
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occurred prior to activation of caspase 8. IR or b-lap alone caused
no evident activations of these caspases. Cytochrome c released
from the mitochondria has been reported to form a complex with
procaspase-9 and apoptotic protease-activating factor-1 (Apaf-1),
resulting in activation of procaspase-9 [14]. Therefore, we
determined whether combined treatment with IR and b-lap
induces the release of cytochrome c from the mitochondria to the
cytosol. As shown in Figure 6B, combined treatment efficiently
raised the level of cytochrome c within the cytosolic fraction for
12 h, whereas IR or b-lap alone did not. We then studied the
requirement of caspase for combined treatment-induced apoptosis
using a broad-spectrum caspase inhibitor, z-VAD-fmk. Figure 6C
shows that z-VAD-fmk effectively prevented activation of caspases
caused by combined treatment. Surprisingly, however, z-VAD-
fmk only partially reduced combined treatment-induced apoptotic
cell death from about 51% to 42% (Fig. 6D). These results indicate
that the apoptotic cell death caused by combined treatment with
IR and b-lap occurs, even though activation of caspases is
inhibited.
Because AIF, a mitochondria-localized flavoprotein, is known to
be involved in the induction of caspase-independent apoptotic cell
death [7], we next investigated whether AIF plays a role in the
induction of cell death by combined treatment with IR and b-lap.
AIF is released from the mitochondria in response to cell death
stimuli, subsequently translocates to the nucleus, where it causes
DNA fragmentation [7]. Subcellular fractionation showed that
combined treatment dramatically induced the nuclear transloca-
tion of AIF, while IR or b-lap alone caused little increase in AIF in
the nucleus (Fig. 6E). Moreover, siRNA-mediated AIF knockdown
effectively reduced combination treatment-induced apoptotic cell
death from 55% to almost control levels (Fig. 6F). These results
suggest that nuclear translocation of AIF is required for the
induction of apoptotic cell death by combined treatment with IR
and b-lap.
To further define the roles of ROS, ERK, ER stress and JNK in
nuclear translocation of AIF after combined treatment with IR
and b-lap, we pretreated NQO1
+-MDA-MB-231 cells with the
corresponding inhibitors, NAC, PD98059, Sal or SP600125, and
examine the subcellular localization of AIF. As shown in
Figure 6G, the nuclear translocation of AIF induced by combined
treatment was completely blocked by pretreatment with NAC,
PD98059, Sal or SP600125. These results show that ROS, ERK,
ER stress and JNK are upstream activators of AIF-mediated cell
death induced by combined treatment with IR and b-lap.
Combined treatment with IR and b-lap induces
mitochondrial translocation of cleaved Bax and
disruption of mitochondrial transmembrane potential
To determine the role of mitochondrial pathway in combined
treatment-induced apoptosis in NQO1
+-MDA-MB-231 cells, we
first examined changes in Bcl-2 and Bax expression levels, and
mitochondrial transmembrane potential. As shown in Figure 7A,
Bax levels were markedly reduced in response to combined
treatment with IR and b-lap, but not in response to individual
treatment with IR or b-lap. The expression levels of Bcl-2 were
unchanged by individual or combined treatment. It has been
reported that Bax is cleaved from a 21 kDa native form to an
Figure 5. The induction of ER stress by combined treatment with IR and b-lap is required for JNK activation. (A) NQO1
+-MDA-MB-231
cells were treated with IR alone, b-lap alone or combination of IR and b-lap for the indicated times. Cell lysates were subjected to Western blot
analysis. The data represent a typical experiment conducted three times with similar results. (B) NQO1
+-MDA-MB-231 cells were treated with IR alone,
b-lap alone or combination of IR and b-lap for 24 h in the presence or absence of Sal (10 mM). After 24 h, the percentage of cells with sub-G1 DNA
content was determined by flow cytometry. Results from three independent experiments are expressed as means 6 SEMs. (C) NQO1
+- MDA-MB-231
cells were treated with IR alone b-lap alone or combination of IR and b-lap for 3 h in the presence or absence of Sal (10 mM). After 3 h, the cells were
incubated with 10 mM H2DCF-DA for 30 min and then analyzed by flow cytometry. Results from three independent experiments are expressed as
means 6 SEMs. (D) NQO1
+-MDA-MB-231 cells were treated with IR alone, b-lap alone or combination of IR and b-lap for 30 min in the presence or
absence of NAC. The data represent a typical experiment conducted three times with similar results. (E) and (F) NQO1
+-MDA-MB-231 cells were
treated with IR alone, b-lap alone or combination of IR and b-lap for 30 min in the presence or absence of Sal, SP600125 or PD98059. The data
represent a typical experiment conducted three times with similar results.
doi:10.1371/journal.pone.0025976.g005
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translocation of 18 kDa cleaved Bax from the cytosol to
mitochondria has been reported to induce a decline in
mitochondrial transmembrane potential and subsequent release
of proapoptogenic proteins from mitochondria [15,16], we
investigated whether combined treatment induces mitochondrial
translocation of cleaved Bax. As shown in Figure 7B and C,
combined treatment with IR and b-lap more effectively increased
the levels of 18 kDa cleaved Bax within the mitochondrial
fraction than individual treatment with IR or b-lap. However,
18 kDa form of Bax was undetectable in whole cell lysates after
combined treatment (Fig. 7C). Because a cathepsin-like protease
has been suggested to be involved in the rapid degradation of
18 kDa form of Bax in the cytosol [17], we pretreated cells with
the protease inhibitor MG132 to know why cleaved Bax was
absent in whole cell lysate after combined treatment with IR and
b-lap. As shown in Figure 7D, when cells were treated with
combination of IR and b-lap in the presence of MG132, cleaved
Bax was detected in whole cell lysate, indicating that cleaved Bax
is readily degraded in the cytosol after combined treatment with
IR and b-lap. Thus, the 18 kDa form of Bax may be unstable in
the cytosol but stable in the mitochondrial fraction after
combined treatment with IR and b-lap. Furthermore, as shown
in Figure 7E, combined treatment significantly disrupted
mitochondrial transmembrane potential in a time-dependent
manner, coinciding with the observed changes in Bax levels.
Taken together, these results demonstrate that combined
treatment-induced cell death involves an alteration in mitochon-
drial transmembrane potential mediated by intracellular redistri-
bution of cleaved Bax.
We next examined the role of ROS, ERK, ER stress and JNK
in the mitochondrial translocation of cleaved Bax and disruption
of mitochondrial transmembrane potential induced by combined
treatment with IR and b-lap. Pretreatment with NAC, PD98059,
Sal or SP600125 significantly attenuated combination treatment-
induced mitochondrial translocation of cleaved Bax and disruption
of mitochondrial transmembrane potential (Fig. 7F and G). These
results indicate that ROS, ERK, ER stress and JNK are upstream
Figure 6. b-lap in combination with IR induces apoptotic cell death via nuclear translocation of AIF. (A) NQO1
+-MDA-MB-231 cells were
treated with IR alone, b-lap alone or combination of IR and b-lap for the indicated times. The data represent a typical experiment conducted three
times with similar results. (B) NQO1
+-MDA-MB-231 cells were treated with IR alone, b-lap alone or combination of IR and b-lap for 12 h. Cytosolic
fractions from NQO1
+-MDA-MB-231 cells were prepared and subjected to Western blot analysis. The data are representative a typical experiment
conducted three times. The data represent a typical experiment conducted three times with similar results. (C) NQO1
+-MDA-MB-231 cells were
treated with combination of IR and b-lap for 12 h in the presence or absence of z-VAD-fmk. The data represent a typical experiment conducted three
times with similar results. (D) NQO1
+-MDA-MB-231 cells were treated with IR alone, b-lap alone or combination of IR and b-lap for 24 h in the
presence or absence of z-VAD-fmk (30 mM). After 24 h, the percentage of the cells with sub-G1 DNA content was determined by flow cytometry.
Results from three independent experiments are expressed as means 6 SEMs. (E) NQO1
+-MDA-MB-231 cells were treated with IR alone, b-lap alone or
combination of IR and b-lap for 24 h. Nuclear fractions from NQO1
+-MDA-MB-231 cells were prepared and subjected to Western blot analysis. The
data are representative a typical experiment conducted three times. (F) NQO1
+-MDA-MB-231 cells were treated with IR alone, b-lap alone or
combination of IR and b-lap for 24 h in the presence or absence of siRNA targeting AIF. After 24 h, the percentage of the cells with sub-G1 DNA
content was determined by flow cytometry. Results from three independent experiments are expressed as means 6 SEMs. (G) NQO1
+-MDA-MB-231
cells were treated with combination of IR and b-lap for 24 h in the presence or absence of NAC, PD98059, Sal or SP600125. Nuclear fractions were
prepared and subjected to Western blot analysis. The data are representative a typical experiment conducted three times.
doi:10.1371/journal.pone.0025976.g006
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combined treatment with IR and b-lap.
Discussion
The aim of our study was to elucidate signaling pathways
involved in b-lap-induced radiosensitization in human breast
cancer cells. We found that b-lap in combination with IR caused
cell death significantly greater than that by individual treatment
alone or more than additive in an NQO1-dependent manner, and
showed that the induction of ER stress by the positive feedback
regulation between ERK and ROS caused JNK activation,
thereby contributing to combined treatment-induced mitochon-
drial apoptotic cell death.
The mechanism of the anti-cancer effect of b-lap alone or in
combination with other treatment modalities has been reported in
recent years [3,4,18–22]. Interestingly, b-lap has been found to
potentiate the effect of taxol, mitomycin C, genistein, cisplatin, and
IR on human cancer cells [3,4,18–22]. We have previously
reported that IR sensitized cells to b-lap by up-regulating NQO1
expression and acitivity [3,18]. In the present study, we observed
that b-lap in combination with IR increases clonogenic and
apoptotic cell death of MDA-MB-231 human breast cancer cells in
an NOQ1-dependent manner (Fig. 1). It has been demonstrated
that b-lap induces radiosenstization by inhibiting the repair of
DNA damage caused by IR [4]. Recently, hyperactivation of poly
(ADP-ribose) polymerase-1 (PARP-1) has been suggested to play
Figure 7. b-lap in combination with IR causes Bax cleavage and translocation of cleaved Bax to mitochondria. (A) NQO1
+-MDA-MB-231
cells were treated with IR alone, b-lap alone or combination of IR and b-lap for the indicated times. Cell lysates were subjected to Western blot
analysis. The data represent a typical experiment conducted three times with similar results. (B) NQO1
+-MDA-MB-231 cells were treated with IR alone,
b-lap alone or combination of IR and b-lap for 12 h. Mitochondrial fractions of NQO1
+-MDA-MB-231 cells were prepared and subjected to Western
blot analysis. The data are representative a typical experiment conducted three times. (C) NQO1
+-MDA-MB-231 cells were treated with IR alone, b-lap
alone or combination of IR and b-lap for 12 h. Whole cell lysates and mitochondrial fractions of NQO1
+-MDA-MB-231 cells were prepared and
subjected to Western blot analysis. The data are representative a typical experiment conducted three times. (D) NQO1
+-MDA-MB-231 cells were
treated with combination of IR and b-lap for 24 h in the presence or absence of MG132. The data are representative a typical experiment conducted
three times. (E) NQO1
+-MDA-MB-231 cells were treated with IR alone, b-lap alone or combination of IR and b-lap for the indicated times. After 12 h,
the concentration of retained DiOC6(3) in cells was measured by flow cytometry. Results from three independent experiments are expressed as
means 6 SEMs. (F) NQO1
+-MDA-MB-231 cells were treated with combination of IR and b-lap for 12 h in the presence or absence of NAC, PD98059, Sal
or SP600125. Mitochondrial fractions were prepared and subjected to Western blot analysis. The data are representative a typical experiment
conducted three times. (G) NQO1
+-MDA-MB-231 cells were treated with combination of IR and b-lap for 12 h in the presence or absence of NAC,
PD98059, Sal or SP600125. After 12 h, the concentration of retained DiOC6(3) in cells was measured by flow cytometry. Results from three
independent experiments are expressed as means 6 SEMs. (H) Schematic model of combined treatment (IR+b-lap)-induced apoptotic cell death.
Combined treatment with IR and b-lap increases mitochondrial apoptotic cell death in an NQO1 dependent manner. As described in detail in the text,
positive feedback regulation between ERK and ROS induced by combined treatment plays a critical role in the induction of ER stress. This enhanced
ER stress is required for JNK activation, which leads to subsequent mitochondrial apoptotic cell death. Moreover, JNK activation induces cleavage of
Bax and mitochondrial translocation of cleaved Bax, which causes loss of mitochondrial transmembrane potential and consequent release of AIF.
doi:10.1371/journal.pone.0025976.g007
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cancer cells that overexpress NQO1 [23]. Furthermore, previous-
ly, it has been reported that ionizing radiation causes a long lasting
elevation of NQO1 activity, which can participate in stabilization
of p53 protein by interfering with 20S proteasome-mediated p53
degradation [24,25]. The stabilized p53 not only activate the
transcriptional expression of various genes involved in apoptosis
and cell cycle arrest by playing as a transcription factor, but it is
also involved in transcription-independent apoptosis [26,27].
It has been reported that ROS are generated during the redox
cycling of b-lap [1]. In the present study, we examined the role of
ROS in the cell death caused by combined treatment with IR and
b-lap. We observed that both the rate and magnitude of ROS
generation were markedly greater (Fig. 2A and B), and thus
apoptosis was greater after combined treatment, compared to
treatment with IR or b-lap alone in NQO1
+-MDA-MB-231 cells
(Fig. 2C).
We demonstrated that the rapid and strong activation of ERK
induced by combined treatment with IR and b-lap is critically
associated with the induction of apoptotic cell death (Fig. 3).
Consistent with previous reports [28–30], we found that b-lap in
combination with IR causes a rapid activation of JNK in NQO1
+-
MDA-MB-231 cells (Fig. 3A). However, activation of p38 MAPK
did not appear to be involved in response to the combined
treatment in NQO1
+-MDA-MB-231 cells (Fig. 3A). In this
context, inhibition of p38 MAPK by pretreating with SB203580
did not alter combined treatment-induced apoptotic cell death in
NQO1
+-MDA-MB-231 cells (Fig. 3B). The JNK activation caused
by combined treatment was first evident within 0.5 h and
decreased in 2 h in NQO1
+-MDA-MB-231 cells (Fig. 3A). This
reduction of JNK activity after 2 h may be due to the action of
phosphatases, such as MAPK phosphatase 2 (MKP2) and -7
(MKP7), which have been reported to decrease the activity of
intracellular MAPK signaling pathways [31–33]. ERK has been
reported to increase the expression and activity of MKP2 and
MKP7, leading to suppression of JNK [31,33]. Similarly, because
our results indicated that ERK activity was elevated for 3 h after
combined treatment in NQO1
+-MDA-MB-231 cells (Fig. 3A),
ERK seems to participate in inducing the expression and activity
of MKP2 or MKP7 for inhibition of JNK activity.
In this study, pretreatment of cells with NAC completely
inhibited combined treatment-induced activation of ERK and
JNK, and subsequent apoptotic cell death, demonstrating that
increased intracellular ROS generation is critical for the activation
of ERK and JNK (Fig. 4A). Increase of intracellular ROS has been
reported to activate the Ras/Raf/ERK pathway by stimulating
receptor tyrosine kinases or directly oxidizing the cysteine residues
of Src, Ras or Raf [34]. Furthermore, several recent reports have
indicated that ASK1, a MAPKKK for JNK activation, forms a
complex with reduced thioredoxin (Trx) in non-stressed cells
[35,36]. Oxidation of Trx by ROS releases ASK1 from the
complex and leads to JNK activation, possibly through dimeriza-
tion of ASK1 [35,36]. Therefore, further studies are required to
clarify the role of ASK1 in the JNK activation that occurs in
response to combined treatment with IR and b-lap.
Interestingly, inhibition of ERK by a targeted siRNA
substantially suppressed combination treatment-induced ROS
generation, whereas siRNA-mediated JNK knockdown did not
(Fig. 4B). These results demonstrate that activation of ERK by
combined treatment substantially contributes to ROS generation,
and indicates the existence of positive feedback regulation between
ERK activation and ROS generation. Several reports have
demonstrated that ERK activation induces phosphorylation of a
serine residue in p47 phox, a subunit of NADPH oxidase, thereby
promoting the translocation of p47 phox to the cellular
membrane, a perquisite for binding to and activation of the
NADPH oxidase responsible for ROS generation [37,38].
Pretreatment of NQO1
+-MDA-MB-231 cells with DPI (dipheny-
lene iodonium), a pharmacological inhibitor of NADPH oxidase,
prior to combined treatment with IR and b-lap, significantly
inhibited the ROS generation and apoptotic cell death caused by
combined treatment (data not shown). Further studies are needed
to elucidate the possible role of ERK in the generation of ROS
generation in response to combined treatment with IR and b-lap.
In agreement with our previous report [39], b-lap alone caused
a slight elevation of ER stress and the induction of ER stress by
combined treatment with IR and b-lap was far more evident than
by b-lap alone (Fig. 5A). Consistent with previous reports that
ROS disrupt ER homeostasis [40–42], we found that inhibition of
ROS generation by pretreatment with NAC significantly sup-
presses the induction of ER stress induced by combined treatment
with IR and b-lap (Fig. 5D). However, Sal, an ER stress inhibitor,
did not affect ROS generation (Fig. 5C), but effectively blocked
apoptotic cell death (Fig. 5B), indicating that the induction of ER
stress is mainly due to ROS generation. It is well established that
ER stress activates JNK [43–46]. In agreement with previous
reports, the suppression of ER stress by Sal effectively blocked
JNK activation (Fig. 5E) and subsequent apoptotic cell death
induced by combined treatment with IR and b-lap (Fig. 5B), but as
mentioned above, it did not inhibit ROS generation (Fig. 5C).
Furthermore, inhibition of JNK by pretreatment with SP600125
did not attenuate combined treatment-induced ER stress (Fig. 4C),
indicating that JNK activation acts downstream of ER stress to
induce apoptotic cell death. These results further support our
conclusion that the induction of ER stress by ROS plays a crucial
role in JNK activation and subsequent apoptotic cell death in
response to combined treatment with IR and b-lap. Sal is known
to selectively block ER stress-induced apoptotic cell death by
inhibiting the dephosphorylation of eIF2a [47,48]. However, it is
unclear how dephosphorylation of eIF2a by Sal suppressed JNK
activation, as we observed in our study. Additional studies are
needed to clarify the inhibitory effect of Sal on the activation of
JNK by ER stress in response to combined treatment with IR and
b-lap.
Caspase activation was reported to be involved in the b-lap-
induced apoptotic cell death of breast cancer cells [2]. Further-
more, although caspase-3 was well known to be the downstream
effector of activated caspase-8 in death receptor-mediated cell
death pathway [14], we observed that the activations of caspase-9
and -3 preceded that of caspase-8 after the combined treatment
with IR and b-lap (Fig. 6A). Several reports also indicated that
caspase-3 can cleave pro-casapsae-8 in vitro [49], and proposed the
possibility that activation of caspase-8 in several anticancer drug
treatments or disease may be mediated by caspase-9 or -3 [50–54].
In addition, combined treatment with IR and b-lap also caused the
release of cytochrome c, expected to initiate activation of caspase-9
(Fig. 6B). Therefore, in agreement with these reports, caspase-9
activation via mitochondrial pathways may play a key role in
activation of caspase-8 by combined treatment with IR and b-lap.
However, interestingly, inhibition of caspases failed to inhibit
apoptosis indicating activation of caspases is not a major or a solo
mechanism for the induction of apoptosis by combined treatment
with IR and b-lap (Fig. 6D).
AIF is known to function in a caspase-independent apoptosis
pathway. Mitochondrial AIF is translocated to the nucleus in
response to death stimuli, where it initiates nuclear condensation
and DNA fragmentation [7,55]. Consistent with these findings, we
observed that AIF was translocated to the nucleus after combined
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activity was required for combined treatment-induced apoptosis
(Fig. 6F). Proteolytic cleavage of native Bax (21 kDa) into an
18 kDa form by calpain has been shown to occur in cancer cells
treated with a variety of chemotherapeutic drugs [15,17]. This
cleaved form of Bax is more potent than the native form in terms
of disruption of mitochondrial transmembrane potential, release of
cytochrome c and AIF from the mitochondria, and subsequent
induction of apoptotic cell death [15,17,56]. We found that
combined treatment with IR and b-lap induced Bax cleavage
without altering Bcl-2 protein levels (Fig. 7A). We also observed
that the cleaved form of Bax was translocated to mitochondria
upon combined treatment (Fig. 7C), coinciding with the observed
changes in mitochondrial transmembrane potential and nuclear
translocation of AIF (Fig. 7B).
In conclusion, we demonstrate that, compared to individual
treatment with IR or b-lap, b-lap in combination with IR was
markedly more potent in causing apoptotic cell death. Combined
treatment induced mitochondrial apoptotic cell death in an NQO1-
dependent manner through positive feedback regulation between
ERKand ROS,whichcontributed totheinductionofERstressand
led to JNK activation and nuclear translocation of AIF (Fig. 7H).
Our results demonstrate that b-lap may effectively improve the
therapeutic efficacy of radiation therapy by targeting NQO1.
Materials and Methods
Reagents
b-lap was purchased from Biomol (Plymouth Meeting, PA), and
was dissolved in DMSO. Antibodies against p38 MAPK, JNK2,
JNK1/2, ERK1/2, Bax, Bcl2, AIF and Nucleoporin p62 were
purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA).
An antibody against mitochondrial heat shock protein 70 (HSP70)
was obtained from Affinity Bioreagents (Golden, CO). Anti-b-
actin, -rabbit IgG, -mouse IgG and N-acetyl-L-cysteine (NAC)
were purchased from Sigma (St. Lous, MO). Antibodies against
phospho-p38 MAPK (Thr180/Tyr182), phospho-JNK1/2
(Thr183/Tyr185), phospho-ERK1/2 (Thr202/Tyr204), phos-
pho-eIF2a (Ser51), eIF2a and active caspase-3 were obtained
from Cell Signaling Technology (Beverly, MA). Inhibitors specific
to JNK (SP600125), MEK/ERK (PD98059), p38 MAPK
(SB203580), caspases (z-VAD-fmk), protease (MG132) and ER
stress (Salubrinal) were purchased from Calbiochem (San Diego,
CA).
Cell culture
Parental NQO1
2-MDA-MB-231 human breast cancer cells,
which are NQO1-deficient, and NQO1
+-MDA-MB-231 human
breast cancer cells, which are stably transfected with NQO1, were
obtained from Dr. David Boothman (University of Texas
Southwestern Medical Center, Dallas, TX). Cells were cultured
in RPMI 1640 medium (Gibco BRL, Grand Island, NY)
supplemented with 10% (v/v) bovine calf serum (Gibco BRL),
penicillin (50 units/ml), and streptomycin (50 mg/ml), in a 37uC
incubator under a mixture of 95% air and 5% CO2.
Irradiation
Cells were exposed to c-rays with a 137Cs irradiation source
(Model 68; J.L. Shepherd and Associates, Glenwood, CA) at a
dose rate of 200–300 cGy/min.
Transfection of small interfering RNA
RNA interference with small interfering RNAs (siRNAs) was
carried out using double-stranded RNA molecules. ERK1/2
siRNA (#6560) was purchased from Cell Signaling Technology
(Beverly, MA). siRNAs against AIF (59-GCA AGU UAC UUA
UCA AGC UTT-39) and JNK2 (59-CUG UAA CUG UUG AGA
UGU ATT-39) were purchased from Bioneer Corporation
(Daejeon, Korea). An unrelated control siRNA (59-CCA CTA
CCT GAG CAC CCA G-39) that targets the green fluorescent
protein DNA sequence was used as a control. For transfection,
cells were seeded on 60-mm dishes and transfected at 30%
confluency with siRNA duplexes (100 nM) using Lipofectamine
2000 (Invitrogen, Carlsbad, CA) in accordance with the
manufacturer’s instructions. Assays were performed 24 h after
transfection.
Quantification of clonogenic death
Various numbers of cells were plated on 60-mm dishes and
treated with 2 mM b-lap, a range of doses of IR (0,4 Gy) or b-lap
(2 mM) in combination with and IR (0,4 Gy). Cells were then
incubated for 14 days at 37uCi n5 %C O 2 incubator to allow
colonies to form. Prior to counting colonies, the culture medium
was decanted, and the cells were fixed in 95% methanol, stained
with 0.5% crystal violet, and the numbers of colonies (.50 cells/
colony) from triplicate dishes were counted. Mean colony numbers
were plotted relative to those formed by unirradiated cells.
Quantification of apoptosis
Cells were collected by trypsinization, washed 2 times with
phosphate-buffered saline (PBS); resuspended in 1 ml PBS
containing 0.1% Triton X-100, 0.1 mM EDTA, 10 mg/ml
DNase-free RNase A, and 2 mg/ml propidium iodide (PI); and
incubated for 1 h in the dark at 37uC. Apoptotic cells were
detected by flow cytometry using a FACSCalibur system (Becton
Dickinson, San Jose, CA). Apoptosis was measured as the
percentage of cells in the sub-G1 population.
Measurement of ROS generation
Cells were incubated at 37uC for 30 min in 10 mM2 9,79-
dichlorofluorescein-diacetate (DCFH-DA; Molecular Probes, Eu-
gene, OR) or 4 mM dihydroethidium (DHE; Molecular Probes,
Eugene, OR), harvested by trypsinization, and washed three times
with cold PBS. ROS levels were determined by flow cytometry, as
described previously [7].
Western blot analysis
Cells were treated with lysis buffer [40 mmol/L Tris-Cl
(pH 8.0), 120 mmol/L NaCl, and 0.1% NP40] supplemented
with protease inhibitors, then centrifuged for 15 min at 12,0006g.
Proteins were separated by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) and transferred to nitrocellulose
membranes (Bio-Rad, Hercules, CA). The membranes were
blocked with 5% nonfat dry milk in Tris-buffered saline and
subsequently incubated for 1 h with primary antibodies at room
temperature. Blots were developed with a peroxidase-conjugated
secondary antibody, and immunoreactive proteins were visualized
using enhanced chemiluminescence reagents (Amersham Biosci-
ences, Piscataway, NJ), as recommended by the manufacturer. b-
actin, Nucleoporin p62 and mitochondrial HSP 70 were used as a
loading control, a nuclear marker, and a mitochondrial marker,
respectively.
Measurement of mitochondrial membrane potential
Cells were incubated for 30 min in 30 nM 3,39-dihexyloxacar-
bocyanine iodide (DiOC6(3); Molecular Probes, Eugene, OR) at
37uC, harvested by trypsinization, and washed three times with
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flow cytometry, as described previously [7].
Preparation of mitochondrial and nuclear fractions
Cells were collected and washed twice in ice-cold PBS,
resuspended in isotonic homogenization buffer [250 mM sucrose,
10 mM KCl, 1.5 mM MgCl2, 1 mM Na-EDTA, 1 mM dithio-
threitol, 0.1 mM phenylmethylsulfonylfluoride, 10 mM Tris-HCl
(pH 7.4)], incubated on ice for 20 min, and homogenized using a
Dounce glass homogenizer (70 strokes) fitted with a loose pestle
(Wheaton, Millville, NJ). Cell homogenates were spun at 306gt o
remove any unbroken cells. Supernatants were then respun for
10 min at 7506g to separate nuclear and mitochondrial fractions.
Each pellet (nuclear fraction) was washed three times with
homogenization buffer, and resuspended in nuclear lysis buffer
[50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% (v/v) NP40, 0.5%
(w/v) sodium deoxycholate] containing protease inhibitors, prior
to Western blot analysis. After pelleting the nuclear fraction, the
supernatant was further subjected to 30 min of centrifugation at
14,0006 g to obtain a mitochondria-rich fraction. Pellets were
washed once with homogenization buffer and then resuspended in
mitochondrial lysis buffer [150 mM NaCl, 50 mM Tris-HCl
(pH 7.5), 1% (v/v) NP40, 0.25% (w/v) sodium deoxycholate, and
1 mM EGTA] containing protease inhibitors prior to Western blot
analysis.
Preparation of cytosolic fractions for cytochrome c
measurement
Cells were collected and washed twice in ice-cold PBS,
resuspended in isotonic homogenization buffer [250 mM sucrose,
10 mM KCl, 1.5 mM MgCl2, 1 mM Na-EDTA, 1 mM dithio-
threitol, 0.1 mM phenylmethylsulfonylfluoride, 10 mM Tris-HCl
(pH 7.4)], incubated on ice for 20 min, and homogenized using a
Dounce glass homogenizer (70 strokes) fitted with a loose pestle
(Wheaton, Millville, NJ). Cell homogenates were spun at 1,0006g
to remove unbroken cells, nuclei, and heavy membranes. The
supernatant was re-spun at 14,0006 g for 30 min to collect the
cytosolic (the supernatant) fractions.
Statistical analysis
All data presented are representative of at least three separate
experiments. Comparisons between groups were analyzed using
Student’s t-test (SPSS Statistics version 17.0, Chicago, IL). p
values,0.05 (indicated by * on figures) were considered to be
significant.
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